Cingulate (CINGW) EPS (Diluted) (2022 - 2026)
Powered by 
Analysis
Cingulate (CINGW) EPS (Diluted) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.70 Bn | 623.94 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 441.16 Bn | 434.59 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 364.92 Bn | 357.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 266.48 Bn | 258.79 Bn | 11.24 Bn | 1.67 |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 52.53 Bn | 45.15 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 44.20 Bn | 44.20 Bn | - | -3.06 |
| 8 | Incyte | 25.27 Bn | 20.74 Bn | 1.57 Bn | 2.81 |
| 9 | United Therapeutics | 21.44 Bn | 18.78 Bn | 683.80 Mn | 7.27 |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | -0.45 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.45 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -1.07 |
| Jun 30, 2025 | -1.14 |
| Mar 31, 2025 | -0.82 |
| Dec 31, 2024 | -3.23 |
| Sep 30, 2024 | -1.85 |
| Jun 30, 2024 | -4.26 |
| Mar 31, 2024 | -5.79 |
| Dec 31, 2023 | -72.70 |
| Sep 30, 2023 | -57.35 |
| Jun 30, 2023 | -107.27 |
| Mar 31, 2023 | -67.14 |
| Dec 31, 2022 | -72.26 |
| Sep 30, 2022 | -67.52 |
| Jun 30, 2022 | -67.74 |